Clinical Trials Directory

Trials / Completed

CompletedNCT04533997

Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

Efficacy and Safety of Ambulatory Hypertonic Saline Therapy in Outpatient Heart Failure Units.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
167 (actual)
Sponsor
Puerta de Hierro University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare intravenous furosemide (125 to 250 mg), isolated or in combination with hypertonic saline solution (2.6% to 3.4%) in the outpatient heart failure patient. The hypothesis is that the combination therapy will increase the diuresis volume at 3 hours and improve congestion parameters at 7 days.

Detailed description

This is a randomized, double-blind, multicenter study of all consecutive patients with decompensated heart failure and signs of volume overload who do not require hospital admission but require intravenous diuretic for relief of congestion. Patients meeting the inclusion criteria, with prior informed consent, will be randomized to treatment with furosemide with hypertonic saline versus isolated furosemide (control group). Complete clinical evaluation, echocardiography, and blood and urinary tests will be performed before the treatment. After 3 hours, diuresis volume, weight and urinary parameters will be evaluated. Efficacy and safety visits will be performed at 7 and 30 days.

Conditions

Interventions

TypeNameDescription
DRUGHypertonic saline solution plus intravenous furosemideIntravenous 60-minutes of hypertonic saline therapy plus furosemide: Furosemide: 125 mg if home oral furosemide ≤160 mg, 250 mg if home oral furosemide \> 160 mg Hypertonic saline solution: Na+ 125-134: 3.4%, Na+ 135-145: 2.6%
DRUGIntravenous furosemideIntravenous 60-minutes infusion of furosemide: 125 mg if home oral furosemide ≤ 160 mg, 250 mg if home oral furosemide \> 160 mg

Timeline

Start date
2021-01-01
Primary completion
2023-05-10
Completion
2023-09-30
First posted
2020-09-01
Last updated
2023-11-09

Locations

14 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04533997. Inclusion in this directory is not an endorsement.